Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents

被引：0
|
作者：
Paik, Julia [1 ]
Al-Salama, Zaina T. [1 ]
机构：
[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
来源：
DRUGS & THERAPY PERSPECTIVES | 2023年 / 39卷 / 09期
关键词：
D O I：
10.1007/s40267-023-01010-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Coronavirus disease 2019 (COVID-19) has a high mortality rate among the elderly, particularly among frailer and older individuals living in long-term care facilities (LTCFs). In Spain, a large number of patients in this priority group had received the COVID-19 vaccine, including the mRNA vaccine BNT162B2, by April 2021. This Adis Summary of Research summarizes the effects of the BNT162B2 mRNA vaccine among residents in an LTCF in Spain, based on an observational study. Vaccination in elderly LTCF residents was not linked with an increased safety risk, with no apparent contraindications even in more frail individuals.
引用
收藏
页码：317 / 318
页数：2
相关论文
共 50 条
  • [31] Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence
    Daungsupawong, H.
    Wiwanitkit, V.
    MEDICINA DE FAMILIA-SEMERGEN, 2024, 50 (04):
  • [32] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
  • [33] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Murdoch, Louise
    Quan, Karen
    Baber, James A.
    Ho, Agnes W. Y.
    Zhang, Ying
    Xu, Xia
    Lu, Claire
    Cooper, David
    Koury, Kenneth
    Lockhart, Stephen P.
    Anderson, Annaliesa S.
    Tuereci, Ozlem
    Sahin, Ugur
    Swanson, Kena A.
    Gruber, William C.
    Kitchin, Nicholas
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2241 - 2258
  • [34] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Louise Murdoch
    Karen Quan
    James A. Baber
    Agnes W. Y. Ho
    Ying Zhang
    Xia Xu
    Claire Lu
    David Cooper
    Kenneth Koury
    Stephen P. Lockhart
    Annaliesa S. Anderson
    Özlem Türeci
    Uğur Şahin
    Kena A. Swanson
    William C. Gruber
    Nicholas Kitchin
    Infectious Diseases and Therapy, 2023, 12 : 2241 - 2258
  • [35] Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
    Oyebanji, Oladayo A.
    Wilson, Brigid
    Keresztesy, Debbie
    Carias, Lenore
    Wilk, Dennis
    Payne, Michael
    Aung, Htin
    St Denis, Kerri
    Lam, Evan C.
    Rowley, Christopher F.
    Berry, Sarah D.
    Cameron, Cheryl M.
    Cameron, Mark J.
    Schmader, Kenneth E.
    Balazs, Alejandro B.
    King, Christopher L.
    Canaday, David H.
    Gravenstein, Stefan
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (11) : 3151 - 3160
  • [36] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Wang, Xiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578
  • [37] Superior immunogenicity and effectiveness of the third, compared to the second, BNT162b2 vaccine dose
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 484 - 484
  • [38] Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency
    Milota, Tomas
    Smetanova, Jitka
    Skotnicova, Aneta
    Rataj, Michal
    Lastovicka, Jan
    Zelena, Hana
    Parackova, Zuzana
    Fejtkova, Martina
    Kanderova, Veronika
    Fronkova, Eva
    Rejlova, Katerina
    Sediva, Anna
    Kalina, Tomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (01): : 306 - +
  • [39] Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
    Frenck, Robert W., Jr.
    Klein, Nicola P.
    Kitchin, Nicholas
    Gurtman, Alejandra
    Absalon, Judith
    Lockhart, Stephen
    Perez, John L.
    Walter, Emmanuel B.
    Senders, Shelly
    Bailey, Ruth
    Swanson, Kena A.
    Ma, Hua
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren V.
    Cooper, David
    Jennings, Timothy
    Brandon, Donald M.
    Thomas, Stephen J.
    Tureci, Ozlem
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 239 - 250
  • [40] Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
    Blain, Hubert
    Tuaillon, Edouard
    Gamon, Lucie
    Pisoni, Amandine
    Miot, Stephanie
    Rolland, Yves
    Picot, Marie-Christine
    Bousquet, Jean
    ALLERGY, 2022, 77 (01) : 271 - 281
12345